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Objective: To determine the rate of positive group B streptococcus (GBS) cultures at 35–37 weeks gestation
in women who have first trimester asymptomatic GBS bacteriuria.
Methods: Pregnant women with asymptomatic first trimester GBS bacteriuria had genital cultures for GBS
performed at 35–37 weeks gestational age. Serotyping was performed by the standard Lancefield capillary
precipitin method.
Results: Fifty-three women with positive urine cultures had genital cultures performed at 35–37 weeks. Sixteen
of the 53 (30.2%; 95% confidence interval: 18.4–44.3%) third trimester vaginal cultures were positive for GBS.
Five of eight (63%) of the women with typable urine serotypes had the same typable serotype in the third
trimester genital culture.
Conclusion: Genitaltractculturesat35–37weeksforGBScorrelatepoorlywithfirsttrimesterasymptomaticGBS
bacteriuria. Recommendations for GBS prophylaxis in labor in women who have first trimester asymptomatic
GBS bacteriuria should be investigated further and reconsidered.
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Perinatal group B streptococcus (GBS) infection is
amajorcauseofneonatalmorbidityandmortality1.
GBScolonizes the maternal lower genital and
gastrointestinal tracts in 20–40% of pregnancies
and causes asymptomatic bacteriuria in about 1%1.
Asymptomatic GBSbacteriuria has been proposed
as a marker of heavy genital tract colonization and
as a risk factor for adverse perinatal outcome
and neonatal disease1–3. Edwards and co-workers
recently reported first trimester GBSbacteriuria
has only a 61% positive predictive value for a
positive GBSgenital culture at the time of labor 4.
The study by Edwards and co-workers demon-
strated that first trimester bacteriuria does not
equate to a positive genital culture at the time of
labor and raised doubts about the need to give
antibiotic prophylaxis based solely on first
trimester GBS bacteriuria.
The current perinatal recommendations by
the Centers for Disease Control (CDC) call for
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atic first trimester bacteriuria, because this is ‘a
marker for heavy genital tract colonization’, and
screening all other women at 35–37 weeks for
vaginal and rectal colonization3. The rate of GBS
genital tract colonization at 35–37 weeks gestation
in women who have had first trimester GBS
bacteriuria has not been reported and the CDC
does not recommend screening these women for
GBSat term. The purpose of this study was to
determine the rate of GBSgenital tract coloniza -
tionat35–37weeksgestationinwomenwhohave
had a first trimester GBSbacteriuria. The correla -
tion of the specific GBSserotypes in each positive
maternal first trimester urine/term genital culture
pair was also assessed.
METHODS
The hospital institutional review board approved
the study protocol. The study participants con-
sisted of pregnant women greater than the age of
15years,receivingprenatalcarefromtheobstetrics
and gynecology residents and staff, at the institu-
tion’s outpatient clinic. All prenatal patients were
screened for asymptomatic bacturia during their
first prenatal visit, with a standard culture from
a self-collected clean catch midstream urine
specimen. Asymptomatic bacteriuria was diag-
nosed when there were at least 104 CFU/ml
of a single organism and identification and anti-
biotic sensitivity of the organism was performed5.
Positive urine cultures were treated with an
appropriate antibiotic and a negative test of
cure was confirmed at the next scheduled prenatal
visit that occurred at least 1 week after completion
of antibiotic therapy. All women with positive
GBScultures had a negative test of cure. If the
organism was identified as GBS, then prophylaxis
was administered in labor6. During the period
of the study, genital cultures for GBSwere not
routinely performed at term and GBSprophylaxis
was performed by a risk factor-based approach6.
Per the clinic’s protocol, cervical cultures for
gonorrhea/chlamydia were routinely obtained
fromallpregnantwomenat35–37weeks.Women
who had a positive GBSurine culture in the first
trimester were eligible to participate in the study.
After verbal consent at 35–37 weeks gestational
age, specimens for GBSwere collected from
study participants at the same time as the cervical
cultures were obtained.
The genital cultures for GBSwere collected
prior to performing the speculum exam for the
cervical cultures. A standard cotton aerobic
bacterial culture swab was gently inserted into the
lower third of the vagina and then in a single
motion, the perineum was swabbed and the
externalanalsphincterwasswabbed.Theswabwas
then placed in Stuart’s transport medium and sent
to the laboratory at room temperature. Specimens
weremaintainedatroomtemperatureandallwere
processed within 4 hours of collection. The swabs
were inoculated into 5 ml of Todd Hewitt broth
containing 0.1 g/l of colistin and 0.015 g/l of
nalidixic acid. The broths were then placed into a
35°C, non-CO2 incubator for 18–24 hours.
Broths were next inoculated onto a blood agar
plate (trypticase soy agar with 5% sheep blood) and
the plates were incubated for 24 hours at 35°Ci n
a5 %C O 2 incubator. The plates were then
examined for colonies consistent with GBS(milky
white, translucent colonies, with or without
hemolysis). Serologic identification was then
performed on the suspect GBScolonies using a
standard commercially available latex agglutina-
tion kit (Abbott Diagnostics, Abbott Park IL,
USA). If agglutination was absent or if no suspect
colonies were present, the blood agar plates were
incubated for an additional 24 hours at 35°Ci n
a5 %C O 2 incubator. The plates were then re-
examined for GBScolonies and if present, sero -
logically identified by latex agglutination. If no
colonies were present, the culture was reported
negative for GBS. GBS serotyping was performed
on the positive urine and genital cultures by the
Lancefield capillary precipitin method utilizing
antisera to polysaccharide antigens Ia, Ib, II, III, IV
andVandproteinantigencpreparedattheCDC7.
The antisera is cross absorbed to ensure that it only
reacts with one specific type. Cultures that did
not react to the antisera were categorized as
non-typable (NT).
The study participants’ physicians were blinded
to the results of the third trimester genital culture.
Outcomesconsistedofthefractionofwomenwith
positive first trimester GBSurine cultures and
positive third trimester genital cultures and the
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culture pair. The Fisher Exact Test, with p < 0.05
considered significant, was utilized to compare
categorical variables. Statistical analysis was
performed using GraphPad Prism version 3.0
(GraphPad Software, San Diego CA, USA).
RESULTS
The study was conducted from January 2001 to
March 2002. There were 2318 pregnant women
cared for in the clinic study population during
this period. Sixty-five first trimester urine cultures
were positive for GBS(2.8%). Twelve of the
65women(18%)withpositiveurinecultureswere
no longer being cared for in our clinic by the third
trimester and genital cultures for GBSwere
unable to be obtained from them. The remaining
53 culture pairs were analyzed. The mean age
(± standard deviation) was 23.4 ± 5 years. Forty
percent of the women were nulliparous. There
were 34 African Americans (64%) and 19 (36%)
were Caucasian. The mean gestational age at
delivery was 39.0 ± 1.6 weeks. There were six
women (11.3%) with preterm delivery, four at
36 weeks and one each at 35 and 34 weeks
gestation. There were no cases of maternal or
neonatal GBS disease.
Sixteenofthe53thirdtrimestervaginalcultures
(30.2%; 95% confidence interval: 18.4–44.3%)
were positive for GBS. The serotypes of the
positiveurinecultureandgenitalculturesarelisted
in Table 1. Serotypes III (32.1%) and Ia (22.6%)
were the most common in the urine cultures.
A greater number of urine cultures than vaginal
cultures were NT – 16/53 (30.2%) versus 1/16
(6.3%) – but this did not reach statistical
significance (p ≤ 0.09). Table 2 lists the serotypes
for each of the 16 positive urine/genital pairs. Five
of eight (63%) of the women with typable urine
serotypes had the same typable serotype in the
third trimester genital culture, while eight (50%)
of the positive genital cultures were in women
whohadNTurineserotypes.Thereweretwotype
II serotypes in the urine and one in the genital
cultures (Table 1). No urine cultures were positive
fortypeII/cwhiletherewerethreepositivegenital
cultures. One of the women with type II in her
urine had a genital culture positive for type II/c.
The other two women with type II/c genital
cultures had completely different serotypes
(III, NT) in their urine (Table 2).
DISCUSSION
In this study, only 30.2% of women with
asymptomatic first trimester GBSbacteriuria had
positive third trimester genital cultures. Of the
30%, 63% had the same typable serotype in
the urine and genital cultures. Interestingly, our
data provide evidence that some women with
asymptomatic first trimester GBSbacteriuria will
haveacompletelydifferentserotypeingenitaltract
cultures at term.
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GBS
serotype
Positive urine culture,
n (%)
Positive genital culture,
n (%)
Ia
Ia/c
Ib
Ib/c
II
II/c
III
IV/c
V
NT
7 (13.2)
5 (9.4)
1 (1.9)
1 (1.9)
2 (3.8)
0
17 (32.1)
1 (1.9)
3 (5.7)
16 (30.2)
4 (25)
0
0
0
1 (6.3)
3 (18.8)
5 (31.3)
0
2 (12.5)
1 (6.3)
Total positive urine cultures = 53; total positive genital
cultures = 16
Table 1 Group B streptococcus serotypes from
positive first trimester urine and 35–37 weeks genital
cultures
Urine culture Genital culture
(2) Ia
Ia
II
(2) III
III
III
NT
NT
NT
(3) NT
(2) NT
(2) Ia
NT
II/c
(2) III
Ia
II/c
Ia
II
II/c
(3) III
(2) V
Table 2 Group B streptococcus serotypes of positive
first trimester urine and 35–37 week genital culture
pairs; n = 16Theurinecultureshadarelativelylargenumber
of NT serotypes. This may have been due to the
organism not producing enough antigen to be
detected by the assay, the loss of the ability to
produce the serotype antigen or the emergence
of new serotypes. The small number of typable
urine/genital culture pairs is a limitation of the
study, but our data suggest the correlation is less
than 1:1. Another potential limitation of this
study was that the third trimester cultures did
not include rectal cultures. The external anal
sphincter was cultured but the swabs were not
passed through the sphincter into the rectum. If
rectal cultures had been obtained, there may have
been a greater number of positive third trimester
cultures. Indeed our positive predictive value
(PPV) of first trimester bacteriuria for a positive
culture at 35–37 weeks was only about 50% of
the PPV that Edwards and co-workers found for
a positive culture at the time of labor4. However
it should be noted that our culture technique
was the same as the one used by Edwards.
The current CDC recommendations for preg-
nant women with first trimester GBSbacteriuria
are based on two studies from 19818 and 19859.
The first study by Wood and Dillon, had only
14 women with GBSbacteriuria and was an
observational study of pregnancy outcome8. The
second study by Persson and co-workers had only
ten women with GBSbacteriuria and evaluated
the relationship between significant and asymp-
tomatic GBSbacteriuria 9. Neither study was
designed to detect the rate or degree of genital
tract GBS colonization at term.
Our data suggest that first trimester bacteriuria
does not automatically equate to heavy genital
tract colonization at 35–37 weeks. Possibly 70%
of women with first trimester asymptomatic
GBSbacteriuria are not at risk for neonatal GBS
transmission at term. If all women with first
trimester bacteriuria had genital tract cultures at
35–37 weeks, then a large number of women may
be able to forgo prophylaxis in labor. For example,
assuming 2% of the approximately four million
deliveries each year have first trimester GBS
bacteriuria, then GBSprophylaxis may not be
necessary in 44 560–65 280 women each year.
This would help to decrease risks of developing
antibiotic resistant GBS, selecting for other
penicillin resistant organisms and serious maternal
drug reactions. We are not currently advocating
the abandonment of the CDC recommendations
for intrapartum prophylaxis of women with first
trimester bacteriuria; however, our data should
provide an impetus for further investigation into
whether this is always necessary.
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